Search results for: 'Laboratory building market'
- Related search terms
- market analysis of rf energy harvesting technolog
- marketing strategy homes industry year 16.9
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
08 Oct 2021  |  North America  |  Market Research
Global Tissue Diagnostics (TDx) Growth Opportunities
Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma
This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Dec 2024  |  Global  |  Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...
$2,450.00
Special Price $2,082.50 save 15 %
-
27 Aug 2020  |  Global  |  Market Research
Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020
Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs
Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...
$3,000.00
Special Price $2,250.00 save 25 %
-
20 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Aug 2024  |  Global  |  Frost Radar
Frost Radar™: Lab Automation and Monitoring Solutions, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies offering lab automation and monitoring solutions for diagnostics labs: hospital and independent labs including multi-chain organized, unorganized, and university labs. Lab automation solutions cover aspects of operations such as pre-pre-analytical, pre-analytical, and post-analytical workflows, whereas lab...
$4,950.00
Special Price $4,207.50 save 15 %
-
10 May 2018  |  North America  |  Market Research
Global Tissue Diagnostics Market, Forecast to 2022
Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market
Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Apr 2023  |  Global  |  Market Outlook
Global Next generation Diagnostics, Outlook 2023
Automation and Digitization Drive the Next Growth Phase Post-COVID-19
As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Aug 2024  |  Global  |  Market Research
Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040,...
$4,950.00
Special Price $4,207.50 save 15 %
-
01 Dec 2022  |  North America  |  Market Research
Global in Vitro Fertilization Services Growth Opportunities
Disruptive Technologies and Innovative Business Models are the Key Drivers in the IVF Services Industry
This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %